Aarti Drugs Limited — Updates, 30-08-2025: General Updates
30-08-2025 | 10:51 pm
30-08-2025 | 10:51 pm
Aarti Drugs faced a `41.44 Cr` penalty/demand from CGST for erroneous IGST refund, now under appeal with a High Court stay. An operational incident (bromine leakage) temporarily halted production at T-150, now resumed. The company enhanced sustainability with 11% R&D spend and Zero Liquid Discharge in 9 of 11 API units.
No comments yet. Be the first to comment!
